The reported incidence of DGF in deceased donors has
increased over time despite the progress in acute rejection
treatment and translates to a 40% decrease in long-term
graft survival (11,12). Between 1985 and 1992 the rate
of DGF in US scientific registries was 14.7% (13). The
incidence rose to 23% in 1998–2004 (3). In themost recent
reports DGF occurred in 2409 patients of all US patients
transplanted in 2008 (21.3%) (14). The increase has been
contemporaneous with the use of expanded criteria donors